Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole plus N-acetylcysteine for infertility in polycystic ovary syndrome
IRCT20221019056244N1Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of letrozole and acetylcysteine in polycystic ovary syndrome (PCOS), sponsored by Tabriz University of Medical Sciences. Started Mar 2023; status: completed.
02
Drugs
letrozoleacetylcysteine
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20221019056244N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221019056244N1.